Managed Ventricular Pacing Protocol for AV Synchrony
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Conventional implantable medical devices often rely on extreme pacing modes that either fail to promote intrinsic conduction or result in excessive ventricular pacing, which can be detrimental to cardiac health, particularly by causing unnatural depolarization and potential arrhythmias.
Innovation Solution
The implementation of Managed Ventricular Pacing (MVP) protocols that selectively operate in atrial-based modes to promote intrinsic conduction, minimizing ventricular pacing through the use of a truncated post-atrial ventricular blanking period (PAVB) and crosstalk window management, allowing for accurate sensing of ventricular events and reducing unnecessary pacing.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DDD/R mode is used to maintain AV synchrony, then AV synchrony is improved, but ventricular pacing increases excessively
Solution Approach 1:
The device dynamically adjusts the post-atrial ventricular blanking period (PAVB) based on detected ventricular events. When a ventricular event is detected within the crosstalk window, the PAVA is extended to prevent false sensing. This dynamic adjustment allows the device to maintain AV synchrony while accurately distinguishing true ventricular events from atrial crosstalk, thereby reducing unnecessary ventricular pacing.
Solution Approach 2:
The invention changes the timing parameter of the post-atrial ventricular blanking period based on detected cardiac events. By extending the PAVA when crosstalk is detected, the system adapts the sensing window to prevent false detection,ไป่ reducing inappropriate ventricular pacing while maintaining proper AV synchrony.
2Measurement precision
If truncated PAVA is used to increase ventricular sensing, then ventricular event detection is improved, but false sensing of atrial crosstalk increases
Solution Approach 1:
The PAVA is made dynamic rather than fixed. It starts with a truncated duration to enable early ventricular sensing, but can be extended when crosstalk is detected. This dynamic behavior allows the system to optimize sensing capability while maintaining reliability by adapting to actual cardiac conditions.
Solution Approach 2:
The system uses feedback from detected ventricular events to adjust the PAVA duration. When a ventricular event is detected within the crosstalk window, this feedback triggers an extension of the PAVA to prevent false sensing in subsequent cycles, thereby maintaining measurement precision while ensuring reliability.
3Reliability
If extended PAVA is used to prevent false sensing, then sensing reliability is improved, but ventricular event detection capability decreases
Solution Approach 1:
Rather than using a consistently extended PAVA, the system dynamically adjusts the blanking period based on detected events. The PAVA is truncated by default to maximize ventricular detection capability, but extended only when and where crosstalk is detected, thus optimizing both reliability and detection capability.
Solution Approach 2:
The PAVA extension is applied locally and selectively rather than globally. Instead of extending the PAVA for all atrial events, the system extends it only for specific events where crosstalk is detected, thereby maintaining optimal ventricular sensing capability while preventing false sensing only where necessary.
Data Source
AI summary
An implantable medical device operates according to a ventricular pacing protocol (VPP) that precludes ventricular pacing in any cardiac cycle where a sensed ventricular event has occurred in the preceding cycle. Improved ventricular sensing, detection and classification is provided.